Ethyl 2-(1,4-dioxaspiro[4.5]decan-8-ylidene)acetate

Catalog No. :
ACLETS416
CAS No. :
51656-91-8
Molecular Formula :
C12H18O4
Molecular Weight :
226.27

IUPAC Name:ethyl 2-(1,4-dioxaspiro[4.5]decan-8-ylidene)acetate

Ethyl 2-(1,4-dioxaspiro[4.5]decan-8-ylidene)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$190.00Login to see priceIn stockInquiry
10g95%$361.00Login to see priceIn stockInquiry
25g95%$749.00Login to see priceIn stockInquiry
100g95%$2547.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 2-(1,4-dioxaspiro[4.5]decan-8-ylidene)acetate
IUPAC Nameethyl 2-(1,4-dioxaspiro[4.5]decan-8-ylidene)acetate
MDL No.MFCD07779434
Molecular FormulaC12H18O4
Molecular Weight226.27
SMILESO=C(OCC)/C=C(CC1)/CCC21OCCO2
InChI KeyUIWISFUVNHCOBJ-UHFFFAOYSA-N
SynonymDS-6600 | Aceticacid,2-(1,4-dioxaspiro[4.5]dec-8-ylidene)-,ethyl ester | NSC649463 | NSC-649463 | ethyl 2-(1,4-dioxaspiro[4.5]decan-8-ylidene)acetate | MFCD07779434 | ethyl2-(1,4-dioxaspiro[4.5]decan-8-ylidene)acetate | EN300-100965 | BCA65691 | DTXSID901
CAS No.51656-91-8
PubChem CID373318

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACLETS416 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRYA186 route compound structure diagram
    ACTRYA1864746-97-8 In Stock
  2. Then
  3. ACLETS416 route product structure diagram
    ACLETS41651656-91-8 In Stock
Inquiry

2. ACLETS416 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTRYA186 route compound structure diagram
    ACTRYA1864746-97-8 In Stock
  4. Then
  5. ACLETS416 route product structure diagram
    ACLETS41651656-91-8 In Stock
Inquiry

Comments (0)